Moreover, LMTK2 down-regulation obtained in PCa LNCaP cell line promotes tumour-forming capacity and proliferation, suggesting that the decrease in LMTK2 expression in PCa patients may promote tumour cells’ proliferation by enhancing AR transcriptional activity. This evidence concerns the gene AR and posterior cortical atrophy.